Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever

Genes and Immunity

Volumn 8, Issue 8, 2007, Pages 699-702

  Everett, B ^a   Cameron, B ^a   Li, H ^a   Vollmer Conna, U ^a   Davenport, T ^b   Hickie, I ^b   Wakefield, D ^a   Vernon, S ^c   Reeves, W C ^c   Lloyd, A R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COXIELLA BURNETII; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GRAM NEGATIVE SEPSIS; HEPATITIS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; PATHOGENESIS; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; Q FEVER; SEROCONVERSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION; ZOONOSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; Q FEVER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

COXIELLA BURNETII; NEGIBACTERIA;

EID: 36949006088     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364428     Document Type: Article

References (23)

1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12: 518-553.
2. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ 2006; 333: 575-578.
3. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401: 811-815.
4. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-625.
5. Honstettre A, Ghigo E, Moynault A, Capo C, Toman R, Akira S et al. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganisation, and inflammatory responses Toll-like receptor 4. J Immunol 2004; 172: 3695-3703.
6. Zamboni DS, Campos MA, Torrecihas ACT, Kiss K, Samuel JE, Gochenbock DT et al. Stimulation of Toll-like receptor 2 by Coxiella burnetii is required for macrophage production of proinflammatory cytokines and resistance to infection. J Biol Chem 2004; 279: 54405-54415.
7. Ben-Ali M, Barbouche M-R, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 (Arg677Trp) polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625-626.
8. Kang TJ, Chae G-T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31: 53-58.
9. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028-1032.
10. Owen R, Roche PW, Hope K, Yohannes K, Roberts A, Liu C et al. Australia's notifiabie diseases status, 2005: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2007; 31: 1-70.
11. Lorenz E, Frees K, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001; 31: 22-24.
12. Sánchez E, Orozco G, López-Nevot MÁ, Jiménez-Alonso J, Martin J. Polymorphisms of Toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54-57.
13. The International HapMap Consortium. The International Hapmap Project. Nature 2003; 426: 789-796.
14. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I et al. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219-223.
15. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162: 1028-1032.
16. Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004; 23: 1921-1986.
17. Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289-1297.
18. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398-6401.
19. von Aulock S, Schröder NWJ, Traub S, Gueinzius K, Lorenz E, Hartung T et al. Heterozygous Toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 2004; 72: 1828-1831.
20. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jorbes M et al. TLR4 mutations are associated with endotoxin hypo-responsiveness in humans. Nat Genet 2000; 25: 187-191.
21. Imahara SD, Jelacic S, Junker CE, O'Keefe GE. The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes. Genes Immun 2005, 6: 37-43.
22. Kinane DF, Shiba H, Stathopoulou PG, Zhao H, Lappin DF, Singh A et al. Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399Ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun 2006; 7: 190-200.
23. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.